Helio Genomics ("Helio" or "the Company"), an AI-driven techbio company specializing in diagnostics technology for cancer ...
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...
Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...
News-Medical.Net on MSN
Integrating AI into colon cancer diagnosis improves the speed and accuracy of detection
A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has ...
News-Medical.Net on MSN
Machine learning tool identifies compounds that induce cancer cells into senescence
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled "SAMP-Score: a morphology-based machine learning classification method for ...
CNW/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based ...
By Kelly Peters,Special to Rice NewsAs artificial intelligence plays an increasingly prominent role in decoding DNA, tracking ...
DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...
The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant ...
Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback